Davies Philip D sold $1.1M of VICR

Davies Philip D (Corp. VP-Global Sales & Mktg.) sold 3,073 shares of VICOR CORP (VICR) at an average of $356.97 ($348.84–$366.68, $1.10M total) across 11 trades on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Davies Philip D
Published Jul 6, 2026, 3:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 3:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Neutral
high confidence
Mentioned
$VICR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The newest fact is the disclosed sale size (~3,073 shares; ~$1.10M) and that it was executed under a pre-arranged Rule 10b5-1 plan; no other company-specific developments are included.

02

Market read

Traders may treat this as routine insider activity with low incremental informational content absent other catalysts.

03

What to watch

The filing does not state tax/option exercise context beyond an open-market sale; without additional filings (e.g., buys, grants, or changes in plan), signal quality is limited.

Relevance 5/10Novelty 4/10Timing: Filed July 6; sale executed July 1 (10b5-1)

Background

The article is an SEC Form 4 insider transaction report for Vicor Corp (VICR).

Company-level read

Ticker impact

$VICRNeutralHigh confidence
Context

SEC Form 4 shows VICR Corp VP-Global Sales & Mktg. Philip D. Davies sold about $1.10M of VICR shares under a 10b5-1 plan on July 1.

Expected impact

Low likelihood of a sustained price move solely from this filing; any impact would be short-lived.

Evidence & confidence

The disclosure is an open-market sale by an officer under a pre-arranged 10b5-1 plan, with no accompanying fundamental catalyst or guidance change in the text.

Market effects

No sector-level read-through provided; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal de-risking or liquidity needs; traders may still watch for follow-on sales/buybacks.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider transaction disclosure.

  • Philip D. Davies

    Corp. VP-Global Sales & Mktg.; sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.